|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K2039/55505 | (2013.01) | ||
| A61K 31/047 | (2006.01) | ||
| C12N2740/16134 | (2013.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61K 33/06 | (2013.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61K 31/047 | (2013.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61K 39/00 | (2013.01) |
| (11) | Patento numeris | 3471765 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17731855.7 |
| Europos patento paraiškos padavimo data | 2017-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/064665 |
| Data | 2017-06-15 |
| (87) | Numeris | WO 2017/216288 |
| Data | 2017-12-21 |
| (30) | Numeris | Data | Šalis |
| 201662350919 P | 2016-06-16 | US |
| (72) |
NGUYEN, Thierry-Thien , NL
BRUNER, Mark , NL
|
| (73) |
Janssen Vaccines & Prevention B.V. ,
Archimedesweg 4, 2333 CN Leiden,
NL
|
| (54) | HIV VACCINE FORMULATION |
| HIV VACCINE FORMULATION |